| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ot-101 | tgf beta-2 messenger rna | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] melanoma[MeSHID:D008545] Pancreatic carcinoma[MeSHID:C562463] Occupational therapy regime[MeSHID:D009788] Disease[MeSHID:D004194] Recurrence (disease attribute)[MeSHID:D012008] Merkel cell carcinoma[MeSHID:D015266] Coronavirus Infections[MeSHID:D018352] Glioblastoma[MeSHID:D005909] |
NA | phase 2/3 | unknown |
| click here to return to the previous page | ||||||||